{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:43:53Z","timestamp":1790855033845,"version":"4.1.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271761 and 82001656"],"award-info":[{"award-number":["82271761 and 82001656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M722008"],"award-info":[{"award-number":["2022M722008"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07816-3","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:49:42Z","timestamp":1741636182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of immune cell metabolism on membranous nephropathy and prospective therapy"],"prefix":"10.1038","volume":"8","author":[{"given":"Xuemei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongnian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-1157","authenticated-orcid":false,"given":"Yukai","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"7816_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"W. G Couser","year":"2017","unstructured":"Couser, W. G. Primary Membranous Nephropathy. Clin. J. Am. Soc. Nephrol. 12, 983\u2013997 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"7816_CR2","doi-asserted-by":"crossref","unstructured":"Ronco, P. et al. Membranous nephropathy. Nat. Rev. Dis. Primers 7, 69 (2021).","DOI":"10.1038\/s41572-021-00303-z"},{"key":"7816_CR3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","volume":"96","author":"A. E van de Logt","year":"2019","unstructured":"van de Logt, A. E. et al. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 96, 1292\u20131302 (2019).","journal-title":"Kidney Int."},{"key":"7816_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2020071082","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi, S. New \u2018Antigens\u2019 in Membranous Nephropathy. J. Am. Soc. Nephrol. 32, 268\u2013278 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"7816_CR5","doi-asserted-by":"publisher","first-page":"102976","DOI":"10.1016\/j.autrev.2021.102976","volume":"21","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Course monitoring of membranous nephropathy: Both autoantibodies and podocytes require multidimensional attention. Autoimmun. Rev. 21, 102976 (2022).","journal-title":"Autoimmun. Rev."},{"key":"7816_CR6","doi-asserted-by":"publisher","first-page":"sfad228","DOI":"10.1093\/ckj\/sfad228","volume":"17","author":"C Murtas","year":"2024","unstructured":"Murtas, C. et al. Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond. Clin. Kidney J. 17, sfad228 (2024).","journal-title":"Clin. Kidney J."},{"key":"7816_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"L. A O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"7816_CR8","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"E. L Pearce","year":"2013","unstructured":"Pearce, E. L. et al. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).","journal-title":"Science"},{"key":"7816_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12098-023-04815-2","volume":"91","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Follicular Helper T Cells and Follicular Regulatory T Cells Involved in Immune Disorders of Idiopathic Membranous Nephropathy. Indian J. Pediatr. 91, 702\u2013708 (2024).","journal-title":"Indian J. Pediatr."},{"key":"7816_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00011-023-01838-5","volume":"73","author":"B Deng","year":"2024","unstructured":"Deng, B. et al. Imbalance of T follicular helper cell subsets trigger the differentiation of pathogenic B cells in idiopathic membranous nephropathy. Inflamm. Res. 73, 485\u2013498 (2024).","journal-title":"Inflamm. Res."},{"key":"7816_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tem.2024.01.005","volume":"35","author":"S Wang","year":"2024","unstructured":"Wang, S., Yang, N. & Zhang, H. Metabolic dysregulation of lymphocytes in autoimmune diseases. Trends Endocrinol. Metab. 35, 624\u2013637 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"7816_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2023.10.035","volume":"105","author":"A. D Kistler","year":"2024","unstructured":"Kistler, A. D. & Salant, D. J. Complement activation and effector pathways in membranous nephropathy. Kidney Int. 105, 473\u2013483 (2024).","journal-title":"Kidney Int."},{"key":"7816_CR13","doi-asserted-by":"publisher","first-page":"155452","DOI":"10.1016\/j.cyto.2021.155452","volume":"141","author":"R Motavalli","year":"2021","unstructured":"Motavalli, R. et al. Altered Th17\/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine 141, 155452 (2021).","journal-title":"Cytokine"},{"key":"7816_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrrheum.2016.147","volume":"12","author":"F Coutant","year":"2016","unstructured":"Coutant, F. & Miossec, P. Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles. Nat. Rev. Rheumatol. 12, 703\u2013715 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7816_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/imm.12910","volume":"154","author":"S. C Funes","year":"2018","unstructured":"Funes, S. C. et al. Implications of macrophage polarization in autoimmunity. Immunology 154, 186\u2013195 (2018).","journal-title":"Immunology"},{"key":"7816_CR16","doi-asserted-by":"publisher","first-page":"1203062","DOI":"10.3389\/fimmu.2023.1203062","volume":"14","author":"M Shi","year":"2023","unstructured":"Shi, M. et al. Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. Front Immunol. 14, 1203062 (2023).","journal-title":"Front Immunol."},{"key":"7816_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E. et al. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"7816_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0272-6386(89)80024-1","volume":"13","author":"E Alexopoulos","year":"1989","unstructured":"Alexopoulos, E. et al. Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates. Am. J. Kidney Dis. 13, 404\u2013412 (1989).","journal-title":"Am. J. Kidney Dis."},{"key":"7816_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.immuni.2017.04.009","volume":"46","author":"M Boothby","year":"2017","unstructured":"Boothby, M. & Rickert, R. C. Metabolic Regulation of the Immune Humoral Response. Immunity 46, 743\u2013755 (2017).","journal-title":"Immunity"},{"key":"7816_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"F. J Weisel","year":"2020","unstructured":"Weisel, F. J. et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat. Immunol. 21, 331\u2013342 (2020).","journal-title":"Nat. Immunol."},{"key":"7816_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ni.3664","volume":"18","author":"J Jellusova","year":"2017","unstructured":"Jellusova, J. et al. Gsk3 is a metabolic checkpoint regulator in B cells. Nat. Immunol. 18, 303\u2013312 (2017).","journal-title":"Nat. Immunol."},{"key":"7816_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"S. Y Lunt","year":"2011","unstructured":"Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev. Cell Dev. Biol. 27, 441\u2013464 (2011).","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"7816_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.06.008","volume":"73","author":"X Ji","year":"2023","unstructured":"Ji, X. et al. Lipid metabolism in regulation of B cell development and autoimmunity. Cytokine Growth Factor Rev. 73, 40\u201351 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"key":"7816_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-021-00936-y","volume":"22","author":"D Chen","year":"2021","unstructured":"Chen, D. et al. Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation. Nat. Immunol. 22, 904\u2013913 (2021).","journal-title":"Nat. Immunol."},{"key":"7816_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin, L., Ersching, J. & Victora, G. D. Germinal Center B Cell Dynamics. Immunity 45, 471\u2013482 (2016).","journal-title":"Immunity"},{"key":"7816_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.20011626","volume":"195","author":"B. P O\u2019Connor","year":"2002","unstructured":"O\u2019Connor, B. P., Cascalho, M. & Noelle, R. J. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J. Exp. Med. 195, 737\u2013745 (2002).","journal-title":"J. Exp. Med."},{"key":"7816_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00018-016-2414-8","volume":"74","author":"J Kunisawa","year":"2017","unstructured":"Kunisawa, J. Metabolic changes during B cell differentiation for the production of intestinal IgA antibody. Cell Mol. Life Sci. 74, 1503\u20131509 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"7816_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/imm.13499","volume":"166","author":"Y Fu","year":"2022","unstructured":"Fu, Y. et al. Immunometabolism shapes B cell fate and functions. Immunology 166, 444\u2013457 (2022).","journal-title":"Immunology"},{"key":"7816_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.celrep.2018.07.084","volume":"24","author":"W. Y Lam","year":"2018","unstructured":"Lam, W. Y. et al. Metabolic and Transcriptional Modules Independently Diversify Plasma Cell Lifespan and Function. Cell Rep. 24, 2479\u20132492.e6 (2018).","journal-title":"Cell Rep."},{"key":"7816_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","volume":"45","author":"W. Y Lam","year":"2016","unstructured":"Lam, W. Y. et al. Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells. Immunity 45, 60\u201373 (2016).","journal-title":"Immunity"},{"key":"7816_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.20170771","volume":"215","author":"A. J Clarke","year":"2018","unstructured":"Clarke, A. J. et al. B1a B cells require autophagy for metabolic homeostasis and self-renewal. J. Exp. Med. 215, 399\u2013413 (2018).","journal-title":"J. Exp. Med."},{"key":"7816_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"E. C Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"7816_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","volume":"31","author":"E. C Rosser","year":"2020","unstructured":"Rosser, E. C. et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab. 31, 837\u2013851.e10 (2020).","journal-title":"Cell Metab."},{"key":"7816_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.it.2024.02.002","volume":"45","author":"A Zotta","year":"2024","unstructured":"Zotta, A., O\u2019Neill, L. A. J. & Yin, M. Unlocking potential: the role of the electron transport chain in immunometabolism. Trends Immunol. 45, 259\u2013273 (2024).","journal-title":"Trends Immunol."},{"key":"7816_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1626","volume":"14","author":"M Barberis","year":"2024","unstructured":"Barberis, M. & Rojas L\u00f3pez, A. Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: Tipping the balance of T- and B-cell interactions. Clin. Transl. Med. 14, e1626 (2024).","journal-title":"Clin. Transl. Med."},{"key":"7816_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.immuni.2018.01.008","volume":"48","author":"W Luo","year":"2018","unstructured":"Luo, W., Weisel, F. & Shlomchik, M. J. B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells. Immunity 48, 313\u2013326.e5 (2018).","journal-title":"Immunity"},{"key":"7816_CR37","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.18632\/oncotarget.23232","volume":"9","author":"S. S Han","year":"2018","unstructured":"Han, S. S. et al. BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. Oncotarget 9, 3292\u20133302 (2018).","journal-title":"Oncotarget"},{"key":"7816_CR38","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"7816_CR39","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20060990","volume":"203","author":"A Patke","year":"2006","unstructured":"Patke, A. et al. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J. Exp. Med. 203, 2551\u20132562 (2006).","journal-title":"J. Exp. Med."},{"key":"7816_CR40","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.41883","volume":"73","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Inositol-Requiring Enzyme 1\u03b1-Mediated Synthesis of Monounsaturated Fatty Acids as a Driver of B Cell Differentiation and Lupus-like Autoimmune Disease. Arthritis Rheumatol. 73, 2314\u20132326 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"7816_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2023.03.010","volume":"35","author":"Q Zeng","year":"2023","unstructured":"Zeng, Q. et al. Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses. Cell Metab. 35, 837\u2013854.e8 (2023).","journal-title":"Cell Metab."},{"key":"7816_CR42","doi-asserted-by":"publisher","first-page":"1232820","DOI":"10.3389\/fimmu.2023.1232820","volume":"14","author":"J Li","year":"2023","unstructured":"Li, J. et al. B cell metabolism in autoimmune diseases: signaling pathways and interventions. Front Immunol. 14, 1232820 (2023).","journal-title":"Front Immunol."},{"key":"7816_CR43","first-page":"891","volume":"20","author":"T Fujita","year":"2006","unstructured":"Fujita, T. et al. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.  Vivo 20, 891\u2013893 (2006).","journal-title":"Vivo"},{"key":"7816_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11255-023-03691-1","volume":"56","author":"Y Qu","year":"2024","unstructured":"Qu, Y. et al. Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy. Int Urol. Nephrol. 56, 635\u2013651 (2024).","journal-title":"Int Urol. Nephrol."},{"key":"7816_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","volume":"181","author":"H Miao","year":"2024","unstructured":"Miao, H. et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br. J. Pharm. 181, 162\u2013179 (2024).","journal-title":"Br. J. Pharm."},{"key":"7816_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clim.2006.09.008","volume":"123","author":"J. M Thurman","year":"2007","unstructured":"Thurman, J. M. Triggers of inflammation after renal ischemia\/reperfusion. Clin. Immunol. 123, 7\u201313 (2007).","journal-title":"Clin. Immunol."},{"key":"7816_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-6-S1-S14","volume":"6","author":"X Gao","year":"2012","unstructured":"Gao, X. et al. Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst. Biol. 6, S14 (2012).","journal-title":"BMC Syst. Biol."},{"key":"7816_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065X.2012.01150.x","volume":"249","author":"G. J van der Windt","year":"2012","unstructured":"van der Windt, G. J. & Pearce, E. L. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249, 27\u201342 (2012).","journal-title":"Immunol. Rev."},{"key":"7816_CR49","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang, R. et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871\u2013882 (2011).","journal-title":"Immunity"},{"key":"7816_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","volume":"44","author":"C Procaccini","year":"2016","unstructured":"Procaccini, C. et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity 44, 406\u2013421 (2016).","journal-title":"Immunity"},{"key":"7816_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"V. A Gerriets","year":"2015","unstructured":"Gerriets, V. A. et al. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J. Clin. Invest. 125, 194\u2013207 (2015).","journal-title":"J. Clin. Invest."},{"key":"7816_CR52","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"R. D Michalek","year":"2011","unstructured":"Michalek, R. D. et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186, 3299\u20133303 (2011).","journal-title":"J. Immunol."},{"key":"7816_CR53","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","volume":"153","author":"C. H Chang","year":"2013","unstructured":"Chang, C. H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239\u20131251 (2013).","journal-title":"Cell"},{"key":"7816_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.immuni.2015.08.017","volume":"43","author":"J. P Ray","year":"2015","unstructured":"Ray, J. P. et al. The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells. Immunity 43, 690\u2013702 (2015).","journal-title":"Immunity"},{"key":"7816_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","volume":"45","author":"H Zeng","year":"2016","unstructured":"Zeng, H. et al. mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation. Immunity 45, 540\u2013554 (2016).","journal-title":"Immunity"},{"key":"7816_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41556-017-0002-2","volume":"20","author":"R Ma","year":"2018","unstructured":"Ma, R. et al. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8(+) T cells. Nat. Cell Biol. 20, 21\u201327 (2018).","journal-title":"Nat. Cell Biol."},{"key":"7816_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","volume":"50","author":"B Reizis","year":"2019","unstructured":"Reizis, B. Plasmacytoid Dendritic Cells: Development, Regulation, and Function. Immunity 50, 37\u201350 (2019).","journal-title":"Immunity"},{"key":"7816_CR58","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med 20, 1327\u20131333 (2014).","journal-title":"Nat. Med"},{"key":"7816_CR59","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.3389\/fimmu.2019.02839","volume":"10","author":"R. W. M Kempkes","year":"2019","unstructured":"Kempkes, R. W. M. et al. Metabolic Pathways Involved in Regulatory T Cell Functionality. Front Immunol. 10, 2839 (2019).","journal-title":"Front Immunol."},{"key":"7816_CR60","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.14-268409","volume":"29","author":"U. H Beier","year":"2015","unstructured":"Beier, U. H. et al. Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival. Faseb j. 29, 2315\u20132326 (2015).","journal-title":"Faseb j."},{"key":"7816_CR61","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s42255-022-00575-z","volume":"4","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics. Nat. Metab. 4, 559\u2013574 (2022).","journal-title":"Nat. Metab."},{"key":"7816_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89160","volume":"2","author":"D Howie","year":"2017","unstructured":"Howie, D. et al. Foxp3 drives oxidative phosphorylation and protection from lipotoxicity. JCI Insight 2, e89160 (2017).","journal-title":"JCI Insight"},{"key":"7816_CR63","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 25, 1282\u20131293.e7 (2017).","journal-title":"Cell Metab."},{"key":"7816_CR64","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","volume":"175","author":"M. O Johnson","year":"2018","unstructured":"Johnson, M. O. et al. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Cell 175, 1780\u20131795.e19 (2018).","journal-title":"Cell"},{"key":"7816_CR65","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"J. D Mezrich","year":"2010","unstructured":"Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190\u20133198 (2010).","journal-title":"J. Immunol."},{"key":"7816_CR66","doi-asserted-by":"publisher","first-page":"12055","DOI":"10.1073\/pnas.0903919106","volume":"106","author":"S. P Cobbold","year":"2009","unstructured":"Cobbold, S. P. et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl. Acad. Sci. USA 106, 12055\u201312060 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7816_CR67","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.kint.2022.12.018","volume":"103","author":"E Hoxha","year":"2023","unstructured":"Hoxha, E. T-cell epitopes of PLA2R1 in membranous nephropathy: another step toward antigen-based immunotherapies. Kidney Int 103, 466\u2013469 (2023).","journal-title":"Kidney Int"},{"key":"7816_CR68","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ni.3415","volume":"17","author":"C. H Chang","year":"2016","unstructured":"Chang, C. H. & Pearce, E. L. Emerging concepts of T cell metabolism as a target of immunotherapy. Nat. Immunol. 17, 364\u2013368 (2016).","journal-title":"Nat. Immunol."},{"key":"7816_CR69","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cmet.2023.12.016","volume":"36","author":"J. Y Fu","year":"2024","unstructured":"Fu, J. Y. et al. Lysine acetyltransferase 6A maintains CD4(+) T cell response via epigenetic reprogramming of glucose metabolism in autoimmunity. Cell Metab. 36, 557\u2013574.e10 (2024).","journal-title":"Cell Metab."},{"key":"7816_CR70","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.1073\/pnas.1919893117","volume":"117","author":"A. P Cribbs","year":"2020","unstructured":"Cribbs, A. P. et al. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proc. Natl. Acad. Sci. USA 117, 6056\u20136066 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7816_CR71","doi-asserted-by":"publisher","first-page":"703972","DOI":"10.3389\/fimmu.2021.703972","volume":"12","author":"M. D Ch\u00e1vez","year":"2021","unstructured":"Ch\u00e1vez, M. D. & Tse, H. M. Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases. Front Immunol. 12, 703972 (2021).","journal-title":"Front Immunol."},{"key":"7816_CR72","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1158\/0008-5472.CAN-08-0025","volume":"68","author":"X He","year":"2008","unstructured":"He, X. et al. PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. Cancer Res 68, 5591\u20135598 (2008).","journal-title":"Cancer Res"},{"key":"7816_CR73","doi-asserted-by":"publisher","first-page":"eabo4250","DOI":"10.1126\/sciadv.abo4250","volume":"8","author":"W Xie","year":"2022","unstructured":"Xie, W. et al. Regulation of autoimmune disease progression by Pik3ip1 through metabolic reprogramming in T cells and therapeutic implications. Sci. Adv. 8, eabo4250 (2022).","journal-title":"Sci. Adv."},{"key":"7816_CR74","doi-asserted-by":"crossref","unstructured":"Lee, G. R., The Balance of Th17 versus Treg Cells in Autoimmunity. Int. J. Mol. Sci.19, 2018.","DOI":"10.3390\/ijms19030730"},{"key":"7816_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36594-x","volume":"14","author":"K Aso","year":"2023","unstructured":"Aso, K. et al. Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nat. Commun. 14, 984 (2023).","journal-title":"Nat. Commun."},{"key":"7816_CR76","doi-asserted-by":"publisher","first-page":"e15167","DOI":"10.7717\/peerj.15167","volume":"11","author":"M Ye","year":"2023","unstructured":"Ye, M. et al. Serum metabolomics analysis reveals metabolite profile and key biomarkers of idiopathic membranous nephropathy. PeerJ 11, e15167 (2023).","journal-title":"PeerJ"},{"key":"7816_CR77","doi-asserted-by":"publisher","first-page":"845767","DOI":"10.3389\/fimmu.2022.845767","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Novel Biomarkers in Membranous Nephropathy. Front Immunol. 13, 845767 (2022).","journal-title":"Front Immunol."},{"key":"7816_CR78","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5414\/CN111059","volume":"101","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. The diversity of peripheral blood T cells and myeloid-derived suppressor cells in patients with idiopathic membranous nephropathy. Clin. Nephrol. 101, 287\u2013297 (2024).","journal-title":"Clin. Nephrol."},{"key":"7816_CR79","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"T Koga","year":"2014","unstructured":"Koga, T. et al. CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J. Clin. Invest 124, 2234\u20132245 (2014).","journal-title":"J. Clin. Invest"},{"key":"7816_CR80","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/08923973.2024.2330636","volume":"46","author":"S Mondal","year":"2024","unstructured":"Mondal, S., Saha, S. & Sur, D. Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis. Immunopharmacol. Immunotoxicol. 46, 330\u2013340 (2024).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"7816_CR81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/08923973.2022.2055568","volume":"44","author":"M Mu\u00f1oz-Urbano","year":"2022","unstructured":"Mu\u00f1oz-Urbano, M., Quintero-Gonz\u00e1lez, D. C. & Vasquez, G. T cell metabolism and possible therapeutic targets in systemic lupus erythematosus: a narrative review. Immunopharmacol. Immunotoxicol. 44, 457\u2013470 (2022).","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"7816_CR82","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41422-019-0161-8","volume":"29","author":"L. R Pelgrom","year":"2019","unstructured":"Pelgrom, L. R. et al. LKB1 expressed in dendritic cells governs the development and expansion of thymus-derived regulatory T cells. Cell Res 29, 406\u2013419 (2019).","journal-title":"Cell Res"},{"key":"7816_CR83","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","volume":"19","author":"S. H M\u00f8ller","year":"2022","unstructured":"M\u00f8ller, S. H., Wang, L. & Ho, P. C. Metabolic programming in dendritic cells tailors immune responses and homeostasis. Cell Mol. Immunol. 19, 370\u2013383 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"7816_CR84","doi-asserted-by":"publisher","first-page":"iii90","DOI":"10.1136\/ard.2008.099176","volume":"67","author":"A. W Thomson","year":"2008","unstructured":"Thomson, A. W. & Robbins, P. D. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann. Rheum. Dis. 67, iii90\u2013iii96 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"7816_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jaut.2008.04.009","volume":"31","author":"A Lleo","year":"2008","unstructured":"Lleo, A. et al. The consequences of apoptosis in autoimmunity. J. Autoimmun. 31, 257\u2013262 (2008).","journal-title":"J. Autoimmun."},{"key":"7816_CR86","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"C. M Krawczyk","year":"2010","unstructured":"Krawczyk, C. M. et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115, 4742\u20134749 (2010).","journal-title":"Blood"},{"key":"7816_CR87","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/ar2886","volume":"12","author":"M. K Crow","year":"2010","unstructured":"Crow, M. K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther. 12, S5 (2010).","journal-title":"Arthritis Res Ther."},{"key":"7816_CR88","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"P. J Murray","year":"2014","unstructured":"Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14\u201320 (2014).","journal-title":"Immunity"},{"key":"7816_CR89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol. Med 30, 96 (2024).","journal-title":"Mol. Med"},{"key":"7816_CR90","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/ki.2011.217","volume":"80","author":"H. J Anders","year":"2011","unstructured":"Anders, H. J. & Ryu, M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80, 915\u2013925 (2011).","journal-title":"Kidney Int"},{"key":"7816_CR91","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pathol-011110-130138","volume":"6","author":"J. I Odegaard","year":"2011","unstructured":"Odegaard, J. I. & Chawla, A. Alternative macrophage activation and metabolism. Annu Rev. Pathol. 6, 275\u2013297 (2011).","journal-title":"Annu Rev. Pathol."},{"key":"7816_CR92","first-page":"420","volume":"5","author":"S Galv\u00e1n-Pe\u00f1a","year":"2014","unstructured":"Galv\u00e1n-Pe\u00f1a, S. & O\u2019Neill, L. A. Metabolic reprograming in macrophage polarization. Front Immunol. 5, 420 (2014).","journal-title":"Front Immunol."},{"key":"7816_CR93","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/icb.2014.11","volume":"92","author":"G. R Steinberg","year":"2014","unstructured":"Steinberg, G. R. & Schertzer, J. D. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease. Immunol. Cell Biol. 92, 340\u2013345 (2014).","journal-title":"Immunol. Cell Biol."},{"key":"7816_CR94","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1017\/erm.2022.35","volume":"24","author":"J Li","year":"2022","unstructured":"Li, J. et al. Metabolic signatures of immune cells in chronic kidney disease. Expert Rev. Mol. Med 24, e40 (2022).","journal-title":"Expert Rev. Mol. Med"},{"key":"7816_CR95","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cmet.2019.01.006","volume":"29","author":"L Du","year":"2019","unstructured":"Du, L. et al. IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties. Cell Metab. 29, 1363\u20131375.e8 (2019).","journal-title":"Cell Metab."},{"key":"7816_CR96","doi-asserted-by":"publisher","first-page":"8821610","DOI":"10.1155\/2023\/8821610","volume":"2023","author":"Y Peng","year":"2023","unstructured":"Peng, Y. et al. Regulatory Mechanism of M1\/M2 Macrophage Polarization in the Development of Autoimmune Diseases. Mediators Inflamm. 2023, 8821610 (2023).","journal-title":"Mediators Inflamm."},{"key":"7816_CR97","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4049\/jimmunol.1402099","volume":"194","author":"M. P Keppel","year":"2015","unstructured":"Keppel, M. P. et al. Activation-specific metabolic requirements for NK Cell IFN-\u03b3 production. J. Immunol. 194, 1954\u20131962 (2015).","journal-title":"J. Immunol."},{"key":"7816_CR98","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Mar\u00e7ais","year":"2014","unstructured":"Mar\u00e7ais, A. et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15, 749\u2013757 (2014).","journal-title":"Nat. Immunol."},{"key":"7816_CR99","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1748-1716.2009.01972.x","volume":"196","author":"R. J Shaw","year":"2009","unstructured":"Shaw, R. J. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol. (Oxf.) 196, 65\u201380 (2009).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"7816_CR100","doi-asserted-by":"publisher","first-page":"16998","DOI":"10.1002\/jcp.28421","volume":"234","author":"S Shahrabi","year":"2019","unstructured":"Shahrabi, S. et al. Flip-flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis. J. Cell Physiol. 234, 16998\u201317010 (2019).","journal-title":"J. Cell Physiol."},{"key":"7816_CR101","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4049\/jimmunol.180.2.850","volume":"180","author":"G Deniz","year":"2008","unstructured":"Deniz, G. et al. Regulatory NK cells suppress antigen-specific T cell responses. J. Immunol. 180, 850\u2013857 (2008).","journal-title":"J. Immunol."},{"key":"7816_CR102","doi-asserted-by":"publisher","first-page":"616853","DOI":"10.3389\/fimmu.2021.616853","volume":"12","author":"E Gianchecchi","year":"2021","unstructured":"Gianchecchi, E., Delfino, D. V. & Fierabracci, A. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases? Front Immunol. 12, 616853 (2021).","journal-title":"Front Immunol."},{"key":"7816_CR103","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrrheum.2017.54","volume":"13","author":"J. P Rhoads","year":"2017","unstructured":"Rhoads, J. P., Major, A. S. & Rathmell, J. C. Fine tuning of immunometabolism for the treatment of rheumatic diseases. Nat. Rev. Rheumatol. 13, 313\u2013320 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7816_CR104","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/1744666X.2021.1964957","volume":"17","author":"S Iwata","year":"2021","unstructured":"Iwata, S. & Tanaka, Y. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus. Expert Rev. Clin. Immunol. 17, 1121\u20131130 (2021).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"7816_CR105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"D. S. W Lee","year":"2021","unstructured":"Lee, D. S. W., Rojas, O. L. & Gommerman, J. L. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat. Rev. Drug Discov. 20, 179\u2013199 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"7816_CR106","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.imbio.2016.11.011","volume":"222","author":"A Sent\u00eds","year":"2017","unstructured":"Sent\u00eds, A. et al. Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology. Immunobiology 222, 620\u2013630 (2017).","journal-title":"Immunobiology"},{"key":"7816_CR107","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/ckj\/sfz127","volume":"12","author":"J. E Rojas-Rivera","year":"2019","unstructured":"Rojas-Rivera, J. E., Carriazo, S. & Ortiz, A. Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal. Clin. Kidney J. 12, 629\u2013638 (2019).","journal-title":"Clin. Kidney J."},{"key":"7816_CR108","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1111\/cas.15055","volume":"112","author":"D Jiang","year":"2021","unstructured":"Jiang, D. et al. Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1\/CD20. Cancer Sci. 112, 3585\u20133597 (2021).","journal-title":"Cancer Sci."},{"key":"7816_CR109","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1600-6143.2010.03413.x","volume":"11","author":"X He","year":"2011","unstructured":"He, X. et al. Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation. Am. J. Transpl. 11, 439\u2013449 (2011).","journal-title":"Am. J. Transpl."},{"key":"7816_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10338-6","volume":"7","author":"A. A Fern\u00e1ndez-Ramos","year":"2017","unstructured":"Fern\u00e1ndez-Ramos, A. A. et al. A comprehensive characterization of the impact of mycophenolic acid on the metabolism of Jurkat T cells. Sci. Rep. 7, 10550 (2017).","journal-title":"Sci. Rep."},{"key":"7816_CR111","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1053\/j.ajkd.2008.04.013","volume":"52","author":"B Dussol","year":"2008","unstructured":"Dussol, B. et al. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial. Am. J. Kidney Dis. 52, 699\u2013705 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"7816_CR112","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.beha.2007.09.003","volume":"20","author":"M. V Mateos","year":"2007","unstructured":"Mateos, M. V. & San Miguel, J. F. Bortezomib in multiple myeloma. Best. Pr. Res Clin. Haematol. 20, 701\u2013715 (2007).","journal-title":"Best. Pr. Res Clin. Haematol."},{"key":"7816_CR113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40170-017-0169-9","volume":"5","author":"E. A Zaal","year":"2017","unstructured":"Zaal, E. A. et al. Bortezomib resistance in multiple myeloma is associated with increased serine synthesis. Cancer Metab. 5, 7 (2017).","journal-title":"Cancer Metab."},{"key":"7816_CR114","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.2300212","volume":"212","author":"T. A Ochoa","year":"2024","unstructured":"Ochoa, T. A. et al. The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells. J. Immunol. 212, 154\u2013164 (2024).","journal-title":"J. Immunol."},{"key":"7816_CR115","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.kint.2021.04.011","volume":"100","author":"S Salhi","year":"2021","unstructured":"Salhi, S. et al. Bortezomib plus dexamethasone for rituximab-resistant PLA2R(+) membranous nephropathy. Kidney Int. 100, 708\u2013709 (2021).","journal-title":"Kidney Int."},{"key":"7816_CR116","doi-asserted-by":"crossref","unstructured":"Becherini, P. et al. CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD(+)-Lowering Agents. Antioxidants(Basel) 12, (2023).","DOI":"10.3390\/antiox12020494"},{"key":"7816_CR117","doi-asserted-by":"crossref","unstructured":"Verhoeven, D., et al., B-cell targeting with anti-CD38 daratumumab: implications for differentiation and memory responses. Life Sci. Alliance 6. (2023).","DOI":"10.26508\/lsa.202302214"},{"key":"7816_CR118","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00000441-200204000-00004","volume":"323","author":"S Sanders","year":"2002","unstructured":"Sanders, S. & Harisdangkul, V. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity. Am. J. Med Sci. 323, 190\u2013193 (2002).","journal-title":"Am. J. Med Sci."},{"key":"7816_CR119","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2021.12.050","volume":"588","author":"A Konishi","year":"2022","unstructured":"Konishi, A. et al. Glucocorticoid imprints a low glucose metabolism onto CD8 T cells and induces the persistent suppression of the immune response. Biochem Biophys. Res Commun. 588, 34\u201340 (2022).","journal-title":"Biochem Biophys. Res Commun."},{"key":"7816_CR120","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/0886022X.2020.1713806","volume":"42","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy. Ren. Fail 42, 122\u2013130 (2020).","journal-title":"Ren. Fail"},{"key":"7816_CR121","doi-asserted-by":"publisher","first-page":"C558","DOI":"10.1152\/ajpcell.00077.2008","volume":"296","author":"J Schl\u00f6ndorff","year":"2009","unstructured":"Schl\u00f6ndorff, J. et al. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am. J. Physiol. Cell Physiol. 296, C558\u2013C569 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"7816_CR122","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000430849","volume":"130","author":"F. C Fervenza","year":"2015","unstructured":"Fervenza, F. C. et al. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron 130, 159\u2013168 (2015).","journal-title":"Nephron"},{"key":"7816_CR123","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ekir.2017.02.004","volume":"2","author":"R Ramachandran","year":"2017","unstructured":"Ramachandran, R. et al. Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide. Kidney Int. Rep. 2, 610\u2013616 (2017).","journal-title":"Kidney Int. Rep."},{"key":"7816_CR124","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1053\/j.ajkd.2013.12.001","volume":"63","author":"A. V Cybulsky","year":"2014","unstructured":"Cybulsky, A. V. et al. Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of glomerulonephritis in adults. Am. J. Kidney Dis. 63, 363\u2013377 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"7816_CR125","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneph.2009.101","volume":"5","author":"M Waldman","year":"2009","unstructured":"Waldman, M. & Austin, H. A. 3rd, Controversies in the treatment of idiopathic membranous nephropathy. Nat. Rev. Nephrol. 5, 469\u2013479 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"7816_CR126","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.3389\/fimmu.2018.02747","volume":"9","author":"J. U Lee","year":"2018","unstructured":"Lee, J. U., Kim, L. K. & Choi, J. M. Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases. Front Immunol. 9, 2747 (2018).","journal-title":"Front Immunol."},{"key":"7816_CR127","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2215\/CJN.09380822","volume":"18","author":"B. F Palmer","year":"2023","unstructured":"Palmer, B. F. & Clegg, D. J. Kidney-Protective Effects of SGLT2 Inhibitors. Clin. J. Am. Soc. Nephrol. 18, 279\u2013289 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"7816_CR128","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon, V. & Verma, S. Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function. Annu Rev. Physiol. 83, 503\u2013528 (2021).","journal-title":"Annu Rev. Physiol."},{"key":"7816_CR129","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"X. Y Zhao","year":"2023","unstructured":"Zhao, X. Y. et al. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Ann. Rheum. Dis. 82, 1328\u20131340 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"7816_CR130","doi-asserted-by":"publisher","first-page":"993869","DOI":"10.3389\/fimmu.2022.993869","volume":"13","author":"X Lv","year":"2022","unstructured":"Lv, X. et al. Canagliflozin reverses Th1\/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy. Front Immunol. 13, 993869 (2022).","journal-title":"Front Immunol."},{"key":"7816_CR131","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cmet.2023.05.001","volume":"35","author":"B. J Jenkins","year":"2023","unstructured":"Jenkins, B. J. et al. Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity. Cell Metab. 35, 1132\u20131146.e9 (2023).","journal-title":"Cell Metab."},{"key":"7816_CR132","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/bjh.18293","volume":"198","author":"J Qin","year":"2022","unstructured":"Qin, J. et al. Empagliflozin modulates CD4(+) T-cell differentiation via metabolic reprogramming in immune thrombocytopenia. Br. J. Haematol. 198, 765\u2013775 (2022).","journal-title":"Br. J. Haematol."},{"key":"7816_CR133","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.arcmed.2019.08.004","volume":"50","author":"A Taherkhani","year":"2019","unstructured":"Taherkhani, A. et al. Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a Diagnostic Panel and Pathogenic Pathways. Arch. Med. Res. 50, 159\u2013169 (2019).","journal-title":"Arch. Med. Res."},{"key":"7816_CR134","doi-asserted-by":"publisher","first-page":"969930","DOI":"10.3389\/fphar.2022.969930","volume":"13","author":"H Miao","year":"2022","unstructured":"Miao, H. et al. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharm. 13, 969930 (2022).","journal-title":"Front Pharm."},{"key":"7816_CR135","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nrneph.2013.129","volume":"9","author":"S Jiang","year":"2013","unstructured":"Jiang, S. et al. The primary glomerulonephritides: a systems biology approach. Nat. Rev. Nephrol. 9, 500\u2013512 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"7816_CR136","doi-asserted-by":"publisher","first-page":"F821","DOI":"10.1152\/ajprenal.00196.2010","volume":"299","author":"J Sieber","year":"2010","unstructured":"Sieber, J. et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am. J. Physiol. Ren. Physiol. 299, F821\u2013F829 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"7816_CR137","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.kint.2020.06.031","volume":"99","author":"H. A Jo","year":"2021","unstructured":"Jo, H. A. et al. Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy. Kidney Int. 99, 443\u2013455 (2021).","journal-title":"Kidney Int."},{"key":"7816_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1756-4","volume":"17","author":"Y. Y Chen","year":"2019","unstructured":"Chen, Y. Y. et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J. Transl. Med. 17, 5 (2019).","journal-title":"J. Transl. Med."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07816-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:49:50Z","timestamp":1741636190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7816"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07816-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"405"}}